Related Experiment Video
Updated: Jun 13, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Viral envelope protein 53R gene highly specific silencing and iridovirus resistance in fish Cells by AmiRNA
Yu-Sin Kim1, Fei Ke, Xiao-Ying Lei
1State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China.
Background:
Envelope protein 53R was identified from frog Rana grylio virus (RGV), a member of the family Iridoviridae, and it plays an important role in the virus assembly. Although inhibition of iridovirus major capsid protein (MCP) by small hairpin RNAs (shRNAs) has been shown to cause resistance to viral infection in vitro, RNA interference (RNAi) to inhibit aquatic animal virus envelope protein gene product has not been reported.
Methodology:
We devised artificial microRNAs (amiRNAs) that target a viral envelope protein gene RGV 53R. By incorporating sequences encoding amiRNAs specific to 53R of RGV into pre-miRNA155 (pSM155) vectors, which use the backbone of natural miR-155 sequence and could intracellularly express 53R-targeted pre-amiRNAs. The pre-amiRNAs could be processed by the RNase III-like enzyme Dicer into 21-25 nt amiRNAs (amiR-53Rs) in fish cell lines. The levels of 53R expression were analyzed through real-time PCR and RGV virions assembly were observed by electronic microscopy in fish cells transfected with or without amiR-53Rs at 72 h of RGV infection.
Conclusion/Significance:
The results argue that viral envelope protein RGV 53R can be silenced and the virions assembly was deficient by amiR-53R-1, and further identified the first amiRNA of envelope protein gene from iridovirus that was able to cause resistance to virus infection in fish cells. The data demonstrate that the viral infection is efficiently suppressed (58%) by amiR-53R-1 targeting positon 36-57 of RGV 53R. Moreover, electron microscopic observations revealed virion assembly defect or reduced virions assembly capacity was closely correlated to expression of amiR-53R-1. Based on real time PCR of the Mx gene, we found no evidence of activation of IFN by amiR-53R-1.
Insights
This study introduces artificial microRNAs (amiRNAs) to silence the frog virus Rana grylio virus (RGV) envelope protein 53R in fish cells. This novel approach effectively inhibits RGV infection and virion assembly, offering a new strategy for antiviral resistance.
Area of Science:
- Virology
- Molecular Biology
- Biotechnology
Background:
- The frog virus Rana grylio virus (RGV) is an aquatic animal pathogen.
- The RGV envelope protein 53R is crucial for virus assembly.
- RNA interference (RNAi) has not been previously reported for inhibiting aquatic animal virus envelope proteins.
Purpose of the Study:
- To develop artificial microRNAs (amiRNAs) targeting the RGV 53R envelope protein gene.
- To investigate the efficacy of amiRNAs in inhibiting RGV replication and virion assembly in fish cells.
- To establish a novel RNAi-based antiviral strategy for aquatic animals.
Main Methods:
- Artificial microRNAs (amiRNAs) targeting RGV 53R were designed and incorporated into pre-miRNA155 vectors.
- These vectors were transfected into fish cell lines to express amiRNAs (amiR-53Rs).
- RGV 53R expression, viral load, and virion assembly were analyzed using real-time PCR and electron microscopy.
Main Results:
- The amiRNA amiR-53R-1 effectively silenced the RGV 53R gene expression.
- Viral infection was suppressed by 58% with amiR-53R-1 targeting a specific region of RGV 53R.
- Electron microscopy confirmed defects or reduced capacity in virion assembly correlated with amiR-53R-1 expression.
Conclusions:
- This study presents the first report of an amiRNA targeting an iridovirus envelope protein gene.
- amiR-53R-1 demonstrates significant potential for inhibiting RGV infection and virion assembly in fish.
- This research establishes a foundation for developing RNAi-based antiviral therapies for aquatic viral diseases.
Related Concept Videos
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release

